TITLE

INFECTIOUS DISEASES

AUTHOR(S)
Rawlins, Matthew
PUB. DATE
December 2010
SOURCE
Journal of Pharmacy Practice & Research;Dec2010, Vol. 40 Issue 4, p326
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses several reports regarding infectious disease research, including a randomized-controlled investigating the effectiveness of tenofovir vaginal gel in the prevention of HIV infection among sexually active women in KwaZulu-Natal, South Africa, a study comparing the pharmacokinetics and therapeutic activity of the innovator drug vancomycin with three generic drugs, and one on the possible mortality associated with the use of the antibiotic cefepime.
ACCESSION #
57408685

 

Related Articles

  • Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes. Barber, Katie E.; Werth, Brian J.; Ireland, Cortney E.; Stone, Nicole E.; Nonejuie, Poochit; Sakoulas, George; Pogliano, Joseph; Rybak, Michael J. // Journal of Antimicrobial Chemotherapy (JAC);Nov2014, Vol. 69 Issue 11, p3006 

    Objectives Ceftobiprole is a broad-spectrum cephalosporin that demonstrates activity against Staphylococcus aureus resistant to methicillin, including strains with reduced susceptibility to glycopeptides and lipopeptides. The addition of this agent provides a potential therapeutic option for...

  • IDSA Guidelines on the Treatment of MRSA Infections in Adults and Children. LAMBERT, MARA // American Family Physician;8/15/2011, Vol. 84 Issue 4, p455 

    The article discusses the evidence-based guidelines released by the Infectious Diseases Society of America (IDSA) on the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. It cites oral antibiotic options to treat skin and soft-tissue infections in patients with...

  • Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study. Forsblom, Erik; Ruotsalainen, Eeva; J√§rvinen, Asko // PLoS ONE;11/29/2016, Vol. 11 Issue 11, p1 

    The objective was to compare the prognostic impact of first week treatment with anti-staphylococcal penicillin (ASP) versus cephalosporin in methicillin-sensitive Staphylococcus aureus bacteremia (MS-SAB). Altogether 580 patients were retrospectively followed and categorized according to first...

  • Pilot Study Comparing Daptomycin And Telavancin In The Treatment Of Skin And Soft Tissue Infections. Evers, R.; Antony, N. I.; Alozie, O.; Antony, S. // Internet Journal of Infectious Diseases;2013, Vol. 12 Issue 2, p1 

    This is a prospective controlled, single blinded, randomized study comparing the efficacy and side effects of daptomycin and telavancin in patients with lower extremity skin and soft tissue infections (SSTI). Forty patients were enrolled with similar SSTI of the lower extremities and received...

  • Early use of Daptomycin Compared to Vancomycin for MRSA Bacteremia. Watkins, Richard R. // Hospital Medicine Alert;Aug2013, Vol. 8 Issue 6, p47 

    A reprint of the article "Early use of Daptomycin Compared to Vancomycin for MRSA Bacteremia" by K. P. Murray et al. which was originally appeared in the July 2013 issue of the journal "Infectious Disease Alert" is presented. The study involved patients with MRSA bacteremia who were treated with...

  • MRSA INFECTIONS: The use of vancomycin and alternative drugs. BORCHARDT, ROY A.; ROLSTON, KENNETH V. I. // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2012, Vol. 25 Issue 6, p22 

    The article discusses suitable treatments for Methicillin-resistant Staphylococcus aureus (MRSA), a frequent cause of serious infections, such as pneumonia, bacteremia, endocarditis and osteomyelitis. With reports of clinical failure with vancomycin therapy, consideration of alternative drugs...

  • The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study. Ji-Hee Hwang; Ju-Hyung Lee; Mi-Kyoung Moon; Ju-Sin Kim; Kyoung-Suk Won; Chang-Seop Lee // Infection & Chemotherapy;Mar2013, Vol. 45 Issue 1, p62 

    Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become a one of the most important causes of nosocomial infections, and use of vancomycin for the treatment of MRSA infection has increased. Unfortunately, vancomycin-resistant enterococcus have been reported, as well as...

  • Which antibiotic for hospital acquired pneumonia caused by MRSA? Muscedere, John // BMJ: British Medical Journal;3/8/2014, Vol. 348 Issue 7948, p10 

    The author discusses whether newer antibiotics to cure hospital-acquired pneumonia caused by the bacterium Methicillin-resistant Staphylococcus aureus (MRSA) are more effective than the conventional vancomycin. A brief comparison between several drugs which include daptomycin, ceftaroline, and...

  • Treating Patients With the Best Drugs. Parra-Ruiz, J. // Clinical Infectious Diseases;Oct2013, Vol. 57 Issue 8, p1218 

    A letter to the editor in response to the article "Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?" by S.J. van Hal and V.G. Fowler in a 2013 issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics